SLOWLY PROGRESSIVE FATAL PATTERN OF SEVERE COVID-19 INFECTION IN PATIENTS TREATED WITH RITUXIMAB

被引：0
|
作者：
Rosenthal, Anton
Jha, Prameeta
Soultan, Kimberly Mae
Vadsaria, Aftab
Yoon, Taek Sang
Pascal, William R.
Kupfer, Yizhak Y.
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.1424
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2090A / 2090A
页数：1
相关论文
共 50 条
  • [41] Nomogram for prediction of fatal outcome in patients with severe COVID-19: a multicenter study
    Yun Yang
    Xiao-Fei Zhu
    Jian Huang
    Cui Chen
    Yang Zheng
    Wei He
    Ling-Hao Zhao
    Qian Gao
    Xuan-Xuan Huang
    Li-Juan Fu
    Yu Zhang
    Yan-Qin Chang
    Huo-Jun Zhang
    Zhi-Jie Lu
    Military Medical Research, 2021, 8 (04) : 535 - 545
  • [42] Neutropenia in patients treated with clozapine during COVID-19 infection
    Marti Bonany, J.
    Perez Carre, M.
    Fortuny Olive, J. R.
    Macias Castellvi, C.
    Carrio Diez, E.
    Sanchez Gonzalez, R.
    Vallve Elias, M.
    Mateu Codina, G. A.
    Martinez Casamitjana, M. I.
    EUROPEAN PSYCHIATRY, 2021, 64 : S658 - S658
  • [43] Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab
    Baffa, Maria E.
    Maglie, Roberto
    Montefusco, Francesca
    Pipito, Carlo
    Senatore, Stefano
    Antiga, Emiliano
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (02) : E135 - E137
  • [44] Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD
    Esmaeili, Sara
    Abbasi, Mohammad Hossein
    Abolmaali, Meysam
    Mojtahed, Mohammad
    Alavi, Seyedeh Niloufar Rafiei
    Soleimani, Sevim
    Mokhtari, Mahisa
    Hatam, Jaber
    Khotbehsara, Samaneh Tanhapour
    Motamed, Mohammad Reza
    Joghataei, Mohammad Taghi
    Mirzaasgari, Zahra
    Moghaddasi, Mehdi
    BMC NEUROLOGY, 2021, 21 (01)
  • [45] Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al
    Guilpain, Philippe
    Le Bihan, Clement
    Foulongne, Vincent
    Taourel, Patrice
    Pansu, Nathalie
    Maria, Alexandre Thibault Jacques
    Jung, Boris
    Larcher, Romaric
    Klouche, Kada
    Le Moing, Vincent
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03)
  • [46] Rituximab and risk of COVID-19 infection and its severity in patients with MS and NMOSD
    Sara Esmaeili
    Mohammad Hossein Abbasi
    Meysam Abolmaali
    Mohammad Mojtahed
    Seyedeh Niloufar Rafiei Alavi
    Sevim Soleimani
    Mahisa Mokhtari
    Jaber Hatam
    Samaneh Tanhapour Khotbehsara
    Mohammad Reza Motamed
    Mohammad Taghi Joghataei
    Zahra Mirzaasgari
    Mehdi Moghaddasi
    BMC Neurology, 21
  • [47] Severe Autoimmune Hemolytic Anemia in COVID-19 Infection, Safely Treated with Steroids
    Hindilerden, Fehmi
    Yonal-Hindilerden, Ipek
    Akar, Emre
    Yesilbag, Zuhal
    Kart-Yasar, Kadriye
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [48] Severe COVID-19 infection in a patient with multiple sclerosis treated with fi ngolimod
    Foerch, Christian
    Friedauer, Lucie
    Bauer, Boris
    Wolf, Timo
    Adam, Elisabeth H.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
  • [49] Pattern of cognitive deficits in severe COVID-19
    Beaud, Valerie
    Crottaz-Herbette, Sonia
    Dunet, Vincent
    Vaucher, Julien
    Bernard-Valnet, Raphael
    Du Pasquier, Renaud
    Bart, Pierre-Alexandre
    Clarke, Stephanie
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (05): : 567 - 568
  • [50] Predictors of Adverse Prognosis Following Hospitalization for COVID-19 Infection in Patients with Immune Mediated Inflammatory Diseases Treated with Rituximab
    Lai, Pei-Hsinq
    Chang, Ting-Wei
    Lan, Shih-Hsun
    Cheng, Chiao-Feng
    Lu, Cheng-Hsun
    Hsieh, Song-Chou
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 431 - 434
12345